Sun, May 11, 2025
Sat, May 10, 2025
Fri, May 9, 2025
Thu, May 8, 2025
Wed, May 7, 2025
Tue, May 6, 2025
Mon, May 5, 2025
Sun, May 4, 2025
Sat, May 3, 2025
Fri, May 2, 2025
Thu, May 1, 2025
Wed, April 30, 2025
Tue, April 29, 2025
Mon, April 28, 2025
Sun, April 27, 2025
Sat, April 26, 2025
Fri, April 25, 2025
Thu, April 24, 2025
Wed, April 23, 2025
Tue, April 22, 2025
Mon, April 21, 2025
Sun, April 20, 2025
[ Sun, Apr 20th ] - BBC
The Video Playlist

Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion


//science-technology.news-articles.net/content/2 .. -to-acquire-springworks-for-usd-3-5-billion.html
Published in Science and Technology on by Daily   Print publication without navigation

Bengaluru: Merck KGaA, a science and technology company, is in late-stage negotiations to buy SpringWorks Therapeutics, a US based commercial-stage biopharmaceutical company for approximately $3.5...

Merck KGaA, a German science and technology company, is reportedly in advanced discussions to acquire SpringWorks Therapeutics, a U.S.-based biopharmaceutical company, for approximately $3.5 billion. The potential acquisition aims to bolster Merck's oncology portfolio, as SpringWorks focuses on developing treatments for severe rare diseases and cancer. The deal, if finalized, would represent a significant expansion of Merck's capabilities in the biopharmaceutical sector, particularly in the area of targeted cancer therapies.

Read the Full Daily Article at:
[ https://medicaldialogues.in/news/industry/pharma/merck-kgaa-in-late-stage-talks-to-acquire-springworks-for-usd-35-billion-147337 ]

Publication Contributing Sources

Similar Science and Technology Publications